Medtronic plc (NYSE:MDT) is one of the top low volatility healthcare stocks to buy now. On July 16, Mizuho raised the firm’s ...

In the latest trading session, Medtronic (MDT) closed at $91.97, marking a -1.04% move from the previous day. The stock fell short of the S&P 500, which registered a gain of 0.02% for the day. At the ...

Medtronic (NYSE:MDT) shares snapped six straight sessions of gains, as the stock was down 1% at $91.99 on Monday.

The company showcases solid financial health with steady revenue, strong free cash flow, and reliable earnings.

Cheap Valuation Too MDT stock is currently trading at a discount compared to the Medical Products industry. Its forward 12-month P/E of 15.56X is lower than the industry’s 21.78X at this moment.

Shares of Medtronic plc (NYSE:MDT – Get Free Report) were down 1.4% on Friday after Truist Financial lowered their price target on the stock from $93.00 to $90.00. Truist Financial currently has ...

My view of MDT stock as a LT investment changed in 2023 after seeing cash flow drop 20% YOY from 2022 to 2023. It was up 14% YOY 2023 to 2024, so this YE 2025 will see cash flow exceed 2022.

In the third quarter of fiscal 2025, Medtronic plc (NYSE:MDT) reported revenue of $8.3 billion, marking a 2.5% year-over-year increase, though slightly below Wall Street’s estimate of $8.33 billion.

MEDTRONIC PLC (MDT) is a large-cap growth stock in the Medical Equipment & Supplies industry. The rating using this strategy is 81% based on the firm’s underlying fundamentals and the stock’s ...

Medtech Solutions S.A. Annual stock financials by MarketWatch. View the latest MDT financial statements, income statements and financial ratios.